Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2026 17:13 ET | Source: Precise Bio Inc.

Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

GREENSBORO, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Precise Bio, Inc. (“Precise Bio” or the “Company”), a clinical-stage regenerative medicine company pioneering bio-printed tissues and organs with...
February 16, 2026 06:50 ET | Source: Research and Markets

$3.25+ Bn Human Microbiome Market Trends and Global Forecasts, 2035, Driven by Advancements in Microbiome Sequencing, Rising Investments in R&D, and Increasing Demand for Personalized Medicine

Dublin, Feb. 16, 2026 (GLOBE NEWSWIRE) -- The "Human Microbiome Market (5th Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Type of Biologic, Route of...
November 19, 2025 09:46 ET | Source: Research and Markets

Lung Transplant Rejection Research Report 2025-2035: TFF Pharmaceuticals and Astellas Lead by Investing Heavily in R&D to Improve Existing Immunosuppressive Therapies, and Develop New Biologics

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Lung Transplant Rejection Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been...
November 19, 2025 08:30 ET | Source: Precise Bio Inc.

Precise Bio Achieves World’s First 3D-Bio-Printed Corneal Implant

Precise Bio Achieves World’s First 3D-Bio-Printed Corneal Implant
November 18, 2025 12:12 ET | Source: Research and Markets

$24.13 Bn Organ Transplant Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Organ Transplant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 14, 2025 17:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
November 06, 2025 18:30 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting

Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the ASN Kidney Week
November 05, 2025 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference

Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
October 17, 2025 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at Kidney Week
September 24, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association